Tomoyuki Wada et al.

Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 antagonist SJP-0132 in Participants with Dry Eye Disease

DOI: 10.1016/j.ajo.2026.01.009